Subscribe

What Patients Really Want from Their Care Team

VBCC - Media Library - Personalized Medicine
Linda Bosserman, MD, FACP
Clinical Assistant Professor
Medical Oncology and Hematology
City of Hope Medical Group
Rancho Cucamonga, CA

As an oncologist who’s practiced for 35 years in the community where I really know my patients, when you listen to patients, they want to be actively involved―they and their family, or a combination.

Sometimes they appoint a family member, but they want to know the truth. They have marketing material, they go on the Internet, but they want to know from their doctor, “What is my health?,” “What’s my disease?”

“What’s the comprehensive treatment program?,” “What can I expect from that, short and long term?,” “What will be my health outcome?” And also, “What is my copay responsibility for this package?”

In our own practice, we have found it essential that every patient, when they go for individual chemotherapy teaching, also have separate financial teaching. People don’t understand their health plans.

They don’t understand their copay responsibilities, and they need time to plan and think about that with their families, and make arrangements, or, when available, apply for copay assistance.

Related Items
Mutation Testing Encouraged for All Patients with Ovarian Cancer
Charles Bankhead
VBCC - June 2016, Vol 7, No 5 published on June 17, 2016 in Personalized Medicine
ESR1 Mutations Predict Worse Survival in ER-Positive Advanced Breast Cancer
Phoebe Starr
VBCC - June 2016, Vol 7, No 5 published on June 17, 2016 in Personalized Medicine
How Do We Measure Quality in the Age of Precision Medicine? Stakeholder Perspectives
Meg Barbor, MPH
VBCC - May 2016, Vol 7, No 4 published on June 3, 2016 in Personalized Medicine
Genomic Instability Score Predicts Survival in Patients with Ovarian Cancer
Charles Bankhead
VBCC - May 2016, Vol 7, No 4 published on June 3, 2016 in Personalized Medicine
Genomics May Explain Poor Survival of African Americans with Kidney Cancer
Phoebe Starr
VBCC - April 2016, Vol 7, No 3 published on April 21, 2016 in Personalized Medicine
Biomarker for Uveal Melanoma Has Immediate Clinical Impact
Phoebe Starr
VBCC - April 2016, Vol 7, No 3 published on April 21, 2016 in Personalized Medicine
Liquid Biopsy Characterizing Circulating Tumor Cells Can Aid Treatment Selection in Prostate Cancer
Phoebe Starr
VBCC - March 2016, Vol 7, No 2 published on March 21, 2016 in Personalized Medicine
Biomarker Panel May Aid Early Detection of Colorectal Cancer
Charles Bankhead
VBCC - March 2016, Vol 7, No 2 published on March 21, 2016 in Personalized Medicine
Genomic Test Supports Treatment Decisions in Prostate Cancer
Phoebe Starr
VBCC - December 2015, Vol 6, No 11 published on December 16, 2015 in Personalized Medicine
Personalized Medicine a Vital Aspect of Palliative Care
Meg Barbor, MPH
VBCC - December 2015, Vol 6, No 11 published on December 16, 2015 in Personalized Medicine
Last modified: September 24, 2015
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology